登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 87626 条符合本次的查询结果， 用时 2.5668041 秒

961. Cancer of Unknown Primary Site.

作者: Joseph A Bellanti.;Dongmei Li.
来源: N Engl J Med. 2025年393卷7期727-728页

962. Cancer of Unknown Primary Site.

作者: Michele Bibas.
来源: N Engl J Med. 2025年393卷7期727页

963. Lorundrostat Efficacy and Safety in Uncontrolled Hypertension. Reply.

作者: Luke J Laffin.;David Rodman.;Steven E Nissen.
来源: N Engl J Med. 2025年393卷7期726-727页

964. Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.

作者: James M Pollock.
来源: N Engl J Med. 2025年393卷7期726页

965. Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.

作者: Elena Burgos.;Beatriz Fernández Fernández.;Alberto Ortiz.
来源: N Engl J Med. 2025年393卷7期725-726页

966. Oral Semaglutide and Cardiovascular Outcomes. Reply.

作者: Darren K McGuire.;Jens-Peter David.;Silvio E Inzucchi.
来源: N Engl J Med. 2025年393卷7期725页

967. Oral Semaglutide and Cardiovascular Outcomes.

作者: Marcel Catão F Dos Santos.;Natália Nóbrega de Lima.;Josivan G Lima.
来源: N Engl J Med. 2025年393卷7期724-725页

968. A Naturally Occurring Gain-of-Function Mutation in Factor VIII.

作者: Joshua T Wischmeyer.;Christine H Baird.;Julian Grandvallet Contreras.;Alexander Tran.;Tzu Phang.;Tian Liu.;Marilyn J Manco-Johnson.
来源: N Engl J Med. 2025年393卷7期722-724页

969. Managing Obesity.

作者: Christos P Kotanidis.;A Michael Lincoff.;Scott A Shikora.
来源: N Engl J Med. 2025年393卷7期719-721页

970. Presymptomatic Treatment of a Genetic Disease with a Small-Molecule Drug.

作者: Charlotte J Sumner.
来源: N Engl J Med. 2025年393卷7期714-717页

971. Expanding the Treat-to-Target Toolbox for Obesity and Diabetes Care.

作者: Craig M Hales.
来源: N Engl J Med. 2025年393卷7期712-714页

972. Case 23-2025: A 28-Year-Old Woman with Respiratory Failure and Abnormal Chest Imaging.

作者: William J Janssen.;Zachary Hartley-Blossom.;Noah C Schoenberg.;Mark F Sabbagh.
来源: N Engl J Med. 2025年393卷7期700-710页

973. Snowman Sign in Pituitary Macroadenoma.

作者: Yuwei Zhou.;Wei Weng.
来源: N Engl J Med. 2025年393卷7期699页

974. Metabolic Dysfunction-Associated Steatotic Liver Disease.

作者: Giovanni Targher.;Luca Valenti.;Christopher D Byrne.
来源: N Engl J Med. 2025年393卷7期683-698页

975. Risdiplam in Presymptomatic Spinal Muscular Atrophy.

作者: Richard S Finkel.;Laurent Servais.;Dmitry Vlodavets.;Edmar Zanoteli.;Maria Mazurkiewicz-Bełdzińska.;Yuh-Jyh Jong.;Aledie Navas-Nazario.;Mohammad Al-Muhaizea.;Alexandra P Q C Araujo.;Leslie Nelson.;Yi Wang.;Birgit Jaber.;Ksenija Gorni.;Heidemarie Kletzl.;Laura Palfreeman.;Michael Rabbia.;Dave Summers.;Eleni Gaki.;Kathryn R Wagner.;Paulo Fontoura.;Michelle A Farrar.;Enrico Bertini.; .
来源: N Engl J Med. 2025年393卷7期671-682页
Risdiplam, an oral pre-messenger RNA splicing modifier, is an efficacious treatment for persons with symptomatic spinal muscular atrophy (SMA). The safety and efficacy of risdiplam in presymptomatic disease are unclear.

976. The Resurgence of Private Law in American Health Care.

作者: Christopher Robertson.;Wendy N Epstein.
来源: N Engl J Med. 2025年393卷7期630-631页

977. The Serendipitous Dance between Life and Death.

作者: Anudari Zorigtbaatar.
来源: N Engl J Med. 2025年393卷7期632-633页

978. Ocular Gnathostomiasis.

作者: Samendra Karkhur.;Ayush Gupta.
来源: N Engl J Med. 2025年393卷7期e9页

979. Neonatal Fc Receptor - Biology and Therapeutics. Reply.

作者: James B Bussel.;Douglas B Cines.;Richard S Blumberg.
来源: N Engl J Med. 2025年393卷6期622-623页

980. Neonatal Fc Receptor - Biology and Therapeutics.

作者: Haoxian Li.;Yong Wu.
来源: N Engl J Med. 2025年393卷6期622页
共有 87626 条符合本次的查询结果， 用时 2.5668041 秒